Sec Form 13G Filing - FS Specialty Lending Fund filing for - 2025-05-29

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  This amendment is being filed because the percentage of class beneficially owned by FS Specialty Lending Fund fell below 5% as of May 9, 2025 (the "Effective Date"). This Schedule 13G shows the number of shares beneficially owned by FS Specialty Lending as of the Effective Date.


SCHEDULE 13G



Comment for Type of Reporting Person:  This amendment is being filed because the percentage of class beneficially owned by FS/EIG Advisor, LLC fell below 5% as of the Effective Date. This Schedule 13G shows the number of shares beneficially owned by FS/EIG Advisor, LLC as of the Effective Date.


SCHEDULE 13G



Comment for Type of Reporting Person:  This amendment is being filed because the percentage of class beneficially owned by FS Investment Advisor, LLC fell below 5% as of the Effective Date. This Schedule 13G shows the number of shares beneficially owned by FS Investment Advisor, LLC as of the Effective Date.


SCHEDULE 13G


 
FS Specialty Lending Fund
 
Signature:/s/ Stephen Sypherd
Name/Title:Stephen Sypherd, General Counsel
Date:05/29/2025
 
FS/EIG Advisor, LLC
 
Signature:/s/ Stephen Sypherd
Name/Title:Stephen Sypherd, Authorized Signatory
Date:05/29/2025
 
FS Investment Advisor, LLC
 
Signature:/s/ Stephen Sypherd
Name/Title:Stephen Sypherd, Authorized Signatory
Date:05/29/2025
primary_doc.xml